US Patent 7972813 Tetrodotoxin-resistant sodium channel alpha subunit

Patent 7972813 was granted and assigned to Vertex Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

79728130

Patent Inventor Names

Christopher Raj Dinesh0

Kenneth McCormack0

Date of Patent

July 5, 2011

Patent Application Number

115401430

Date Filed

September 29, 2006

Patent Citations Received

‌

US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods

‌

US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies

‌

US Patent 11773175 Antibodies, uses and methods

Patent Primary Examiner

‌

Jane Zara

Patent abstract

The present invention is directed to a chimp sodium channel alpha subunit and methods and compositions for making and using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7972813 Tetrodotoxin-resistant sodium channel alpha subunit

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API